Quantitative Systematic Strategies’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-14,160
| Closed | -$1.41M | – | 695 |
|
|
2019
Q3 | $1.41M | Sell |
14,160
-2,979
| -17% | -$283K | 0.32% | 96 |
|
|
2019
Q2 | $1.58M | Buy |
+17,139
| New | +$1.63M | 0.3% | 113 |
|
|
2019
Q1 | – | Sell |
-6,022
| Closed | -$386K | – | 797 |
|
|
2018
Q4 | $386K | Buy |
+6,022
| New | +$445K | 0.09% | 334 |
|
|
2018
Q3 | – | Sell |
-4,413
| Closed | -$350K | – | 895 |
|
|
2018
Q2 | $350K | Sell |
4,413
-13,380
| -75% | -$1.11M | 0.06% | 427 |
|
|
2018
Q1 | $1.59M | Buy |
17,793
+15,508
| +679% | +$1.49M | 0.34% | 78 |
|
|
2017
Q4 | $238K | Buy |
+2,285
| New | +$258K | 0.06% | 457 |
|
|
2017
Q1 | – | Sell |
-3,828
| Closed | -$448K | – | 473 |
|
|
2016
Q4 | $448K | Buy |
3,828
+1,132
| +42% | +$126K | 0.18% | 213 |
|
|
2016
Q3 | $277K | Sell |
2,696
-1,006
| -27% | -$109K | 0.1% | 282 |
|
|
2016
Q2 | $366K | Sell |
3,702
-9,738
| -72% | -$1.01M | 0.17% | 200 |
|
|
2016
Q1 | $1.33M | Buy |
+13,440
| New | +$1.38M | 0.51% | 81 |
|
|
2015
Q4 | – | Sell |
-3,560
| Closed | -$401K | – | 990 |
|
|
2015
Q3 | $401K | Buy |
+3,560
| New | +$442K | 0.2% | 205 |
|
|
2015
Q2 | – | Sell |
-3,333
| Closed | -$400K | – | 691 |
|
|
2015
Q1 | $400K | Buy |
+3,333
| New | +$398K | 0.11% | 290 |
|
|
2014
Q4 | – | Sell |
-3,018
| Closed | -$288K | – | 500 |
|
|
2014
Q3 | $288K | Buy |
+3,018
| New | +$272K | 0.17% | 218 |
|
Other funds holding CELG
Quantitative Systematic Strategies's CELG Position: Q4 2019 in Review
Quantitative Systematic Strategies sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 14,160 shares — an estimated $1.41M sold.
Quantitative Systematic Strategies first reported a position in CELG in Q3 2014 and held it in 13 quarters. The position peaked at $1.59M in Q1 2018. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Quantitative Systematic Strategies reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Quantitative Systematic Strategies sold 14,160 Celgene Corp shares in Q4 2019, an estimated $1.41M.
- Quantitative Systematic Strategies first reported a position in Celgene Corp in Q3 2014 and held it in 13 quarters.
- Quantitative Systematic Strategies's Celgene Corp position peaked at $1.59M in Q1 2018.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Quantitative Systematic Strategies's 13F filing for Q4 2019, filed 11 Feb 2020.